Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Shah, Han Kim, O. James, M. Parker, E. Wu, R. Bonow, R. Judd, R. Kim (2013)
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease.JAMA, 309 9
R. Kwong, A. Chan, K. Brown, Carmen Chan, H. Reynolds, Sui Tsang, R. Davis (2006)
Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery DiseaseCirculation, 113
E. Schelbert, J. Cao, S. Sigurdsson, T. Aspelund, P. Kellman, A. Aletras, C. Dyke, G. Thorgeirsson, G. Eiriksdottir, L. Launer, V. Gudnason, T. Harris, A. Arai (2012)
Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.JAMA, 308 9
G. Bardy, Kerry Lee, D. Mark, J. Poole, D. Packer, R. Boineau, M. Domanski, C. Troutman, Jill Anderson, G. Johnson, S. McNulty, N. Clapp-Channing, L. Davidson-Ray, Elizabeth Fraulo, D. Fishbein, R. Luceri, J. Ip (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.The New England journal of medicine, 352 3
AG Fraser, PT Buser, JJ Bax (2006)
The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology., 27
J. Ip, S. Kantipudi, A. Khasnis, I. Virk, S. Khan (2004)
Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated CardiomyopathyCongestive Heart Failure, 10
F. Baer, P. Theissen, C. Schneider, E. Voth, U. Sechtem, H. Schicha, E. Erdmann (1998)
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization.Journal of the American College of Cardiology, 31 5
K. Thygesen, J. Alpert, A. Jaffe, M. Simoons, B. Chaitman, H. White, K. Thygesen, H. Katus, F. Apple, B. Lindahl, D. Morrow, Bernard Chaitman, P. Clemmensen, P. Johanson, H. Hod, R. Underwood, Jeroen Bax, R. Bonow, F. Pinto, R. Gibbons, K. Fox, D. Atar, L. Newby, M. Galvani, C. Hamm, B. Uretsky, P. Steg, W. Wijns, J. Bassand, P. Menasche, J. Ravkilde, E. Ohman, E. Antman, L. Wallentin, P. Armstrong, J. Januzzi, M. Nieminen, M. Gheorghiade, G. Filippatos, R. Luepker, S. Fortmann, W. Rosamond, D. Levy, D. Wood, Sidney Smith, D. Hu, J. López-Sendón, R. Robertson, D. Weaver, M. Tendera, A. Bove, A. Parkhomenko, E. Vasilieva, S. Mendis (2013)
Third universal definition of myocardial infarctionNature Reviews Cardiology, 9
J. McCrohon, J. Moon, S. Prasad, W. McKenna, C. Lorenz, A. Coats, D. Pennell (2003)
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic ResonanceCirculation, 108
K. Thygesen, J. Alpert, H. White (2008)
Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, 9
R. Assomull, C. Shakespeare, P. Kalra, G. Lloyd, A. Gulati, J. Strange, W. Bradlow, J. Lyne, J. Keegan, P. Poole‐Wilson, M. Cowie, D. Pennell, S. Prasad (2011)
Role of Cardiovascular Magnetic Resonance as a Gatekeeper to Invasive Coronary Angiography in Patients Presenting With Heart Failure of Unknown EtiologyCirculation, 124
(2005)
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure
R. Kim, D. Fieno, T. Parrish, Kathleen Harris, Enn‐ling Chen, Orlando Simonetti, J. Bundy, J. Finn, F. Klocke, R. Judd (1999)
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.Circulation, 100 19
A. Gulati, A. Jabbour, T. Ismail, K. Guha, Jahanzaib Khwaja, S. Raza, Kishen Morarji, Tristan Brown, Nizar Ismail, M. Dweck, E. Pietro, M. Roughton, R. Wage, Y. Daryani, R. O’Hanlon, M. Sheppard, F. Alpendurada, A. Lyon, S. Cook, M. Cowie, R. Assomull, D. Pennell, S. Prasad (2013)
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.JAMA, 309 9
R. Kim, E. Wu, Allen Rafael, Enn‐ling Chen, M. Parker, O. Simonetti, F. Klocke, R. Bonow, R. Judd (2000)
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.The New England journal of medicine, 343 20
A. Fraser, P. Buser, Jeroen Bax, W. Dassen, P. Nihoyannopoulos, J. Schwitter, J. Knuuti, M. Höher, F. Bengel, A. Szatmári (2006)
The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European AssociatEuropean journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 7 4
R. Bonow, G. Maurer, Kerry Lee, T. Holly, P. Binkley, P. Desvigne‐Nickens, J. Drożdż, P. Farsky, A. Feldman, T. Doenst, R. Michler, D. Berman, J. Nicolau, P. Pellikka, Krzysztof Wróbel, N. Alotti, F. Asch, L. Favaloro, Lilin She, E. Velazquez, Robert Jones, J. Panza (2011)
Myocardial viability and survival in ischemic left ventricular dysfunction.The New England journal of medicine, 364 17
F. Baer, P. Theissen, E. Voth, C. Schneider, H. Schicha, U. Sechtem (1994)
Morphologic correlate of pathologic Q waves as assessed by gradient-echo magnetic resonance imaging.The American journal of cardiology, 74 5
(2005)
Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure
A. Kadish, A. Dyer, J. Daubert, R. Quigg, N. Estes, Kelley Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, William Sanders, A. Schaechter, Joseph Levine (2004)
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.The New England journal of medicine, 350 21
Editorials represent the opinions EDITORIAL of the authors and JAMA and not those of the American Medical Association. What Does Late Gadolinium Enhance? higher risk for multiple cardiovascular events including all- Deepak K. Gupta, MD cause mortality as well as those attributed to sudden car- Raymond Y. Kwong, MD, MPH diac death. Patients with midwall LGE had a nearly 3 times Marc A. Pfeffer, MD, PhD increased risk of death compared with those without mid- wall LGE over a median of 5 years of follow up. Impor- HE EVOLVING CAPACITY TO NONINVASIVELY IMAGE tantly, the authors suggested that midwall LGE reclassified the contracting heart and assess structure, func- risk of adverse prognosis in patients with DCM above that tion, perfusion, and viability has led to remarkable conferred by left ventricular ejection fraction (LVEF). These Tprogress in the ability to more accurately make new findings in DCM build on the existing literature re- cardiovascular diagnoses and to augment prognostic capa- garding the relationship between the presence and extent bilities. For the cardiovascular specialist, when guided by of LGE and reduced survival in patients with ischemic car- patients’ history and physical examination results, the 7,8 diomyopathy. transthoracic echocardiogram has earned its
JAMA – American Medical Association
Published: Mar 6, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.